drugset / Trial / NCT05664880
A PiLot ClinicaL TrIal of ParicAlcitol for ChroNiC PancrEatitis
Phase 0
Recruiting
24 enrolled
Cedars-Sinai Medical Center
National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) · collab
RandomizedParallel-groupQuadruple-blindTreatment
Summary
The purpose of this pilot study to examine the feasibility and acceptability of paricalcitol in adults with Chronic Pancreatitis (CP).
Timeline
- Start
- 2023-06-01
- Primary completion
- 2026-06-01
- Completion
- 2026-12
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Paricalcitol | Other / unclassified | 2 ug | Oral |